FEROX STRATEGIES

Lobbying for FRESENIUS KABI USA LLC · Generic and biosimilar pharmaceutical manufacturer

Filing Registration

1st Quarter (Jan 1 - Mar 31) 2025 · Illinois · posted Mar 18, 2025

Lobbying activity 2

Health Issues

Policy and oversight related to generic and biosimilar industry issues.

Pharmacy

Policy and oversight related to generic and biosimilar industry issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.